Krishna Vaddi

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PRLD

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$615,441	—	—	$412,744	$309,465	$10,350	$1,348,000
2024	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$594,167	—	—	$1,446,379	$276,575	$10,350	$2,327,471
2023	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$572,667	—	—	$1,735,873	$330,625	$2,624	$2,641,789
2022	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$558,333	—	—	$2,498,244	$238,425	$9,150	$3,304,152
2021	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$544,192	—	—	$6,224,234	$265,688	$8,700	$7,042,814
2020	Prelude Therapeutics Inc (PRLD)	Ph.D.^(^^3)^ Chief Executive Officer	$417,058	—	$1,409,998	$9,576,741	$228,667	—	$11,632,464
2019	Prelude Therapeutics Inc (PRLD)	Chief Executive Officer	$315,000	—	$815,000	$828,125	$121,275	—	$2,079,400

No earnings-call appearances or filed executive changes recorded yet.